EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

The Role of FNDC5/Irisin in Cardiovascular Disease

Maciej Grzeszczuk iD, Piotr Dzięgiel, Katarzyna Nowińska iD

Cells · 02.02.2024 · 13 (3) · 277

DOI: 10.3390/cells13030277 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Cells, online erschienen am 02.02.2024. Verfasst von Maciej Grzeszczuk und 2 weiteren Autor:innen. Beteiligte Einrichtung: Division of Histology and Embryology, Department of Human Morphology and Embryology, Wroclaw Medical University, 50-368 Wroclaw, Poland. Hauptthemen laut MEDLINE: Cardiovascular Diseases, Myocardial Infarction. Die Arbeit wurde bisher 25-mal zitiert (Crossref) und nennt 115 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Disorders of cardiomyocyte metabolism play a crucial role in many cardiovascular diseases, such as myocardial infarction, heart failure and ischemia–reperfusion injury. In myocardial infarction, cardiomyocyte metabolism is regulated by mitochondrial changes and biogenesis, which allows energy homeostasis. There are many proteins in cells that regulate and control metabolic processes. One of them is irisin (Ir), which is released from the transmembrane protein FNDC5. Initial studies indicated that Ir is a myokine secreted mainly by skeletal muscles. Further studies showed that Ir was also present in various tissues. However, its highest levels were observed in cardiomyocytes. Ir is responsible for many processes, including the conversion of white adipose tissue (WAT) to brown adipose tissue (BAT) by increasing the expression of thermogenin (UCP1). In addition, Ir affects mitochondrial biogenesis. Therefore, the levels of FNDC5/Ir in the blood and myocardium may be important in cardiovascular disease. This review discusses the current knowledge about the role of FNDC5/Ir in cardiovascular disease.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Cardiovascular DiseasesMyocardial InfarctionHumansFibronectinsAdipose Tissue, WhiteMuscle, SkeletalTranscription Factors

Stichwörter der Autor:innen

FNDC5fibronectin type III domain-containing protein 5irisinmyocardial infarction

Substanzen

FibronectinsTranscription FactorsFNDC5 protein, human

Autor:innen und Institutionen

  • Division of Histology and Embryology, Department of Human Morphology and Embryology, Wroclaw Medical University, 50-368 Wroclaw, Poland.
  • Department of Human Biology, Faculty of Physiotherapy, Wroclaw University of Health and Sport Sciences, 51-612 Wroclaw, Poland.

ORCID-Profile: Maciej Grzeszczuk, Katarzyna Nowińska

Zitieren

APA

Grzeszczuk, M., Dzięgiel, P., & Nowińska, K. (2024). The Role of FNDC5/Irisin in Cardiovascular Disease. Cells, 13(3), 277. https://doi.org/10.3390/cells13030277

Vancouver

Grzeszczuk M, Dzięgiel P, Nowińska K. The Role of FNDC5/Irisin in Cardiovascular Disease. Cells. 2024;13(3):277. doi:10.3390/cells13030277

BibTeX
@article{Grzeszczuk2024,
  author = {Grzeszczuk, Maciej and Dzięgiel, Piotr and Nowińska, Katarzyna},
  title = {The Role of FNDC5/Irisin in Cardiovascular Disease},
  journal = {Cells},
  year = {2024},
  volume = {13},
  number = {3},
  pages = {277},
  doi = {10.3390/cells13030277}
}
Kostenlos starten →